Exits

Namesort icon Description Event Date Acquired By
<a href="http://www.acceleronpharma.com/" target="_blank">Acceleron Pharma, Inc.</a> Discovering, developing and commercializing novel protein therapeutics for cancer and rare diseases. IPO 2013
<a href="http://www.bdbiosciences.com/instruments/accuri/" target="_blank">Accuri Cytometers, Inc.</a> Developing and manufacturing revolutionary, low-cost, high-performance flow cytometers for researchers. Acquired 2011 <a href="http://www.bdbiosciences.com/instruments/accuri/" target="_blank">Becton, Dickinson and Company</a>
<a href="http://www.adnexustx.com" target="_blank">Adnexus Therapeutics</a> Developing new class of therapeutic compounds. Acquired 2007 <a href="http://www.bms.com" target="_blank">Bristol-Myers Squibb</a>
<a href="http://www.adolor.com/" target="_blank">Adolor Corporation</a> Discovery, development and commercialization of prescription pain management products IPO 2000
<a href="http://www.agios.com/" target="_blank">Agios Pharmaceuticals, Inc.</a> Discovering and developing novel drugs to treat cancer and inborn errors of metabolism. IPO 2013
<a href="http://www.alere.com" target="_blank">Alere Medical Incorporated</a> Internet-based medical monitoring systems for patients with chronic diseases Acquired 2007 <a href="http://www.alere.com" target="_blank">Inverness Medical Innovations</a>
Anesta Corporation Powerful drug system to control the severe pain of end stage cancer Acquired 2000 <a href="http://www.cephalon.com" target="_blank">Cephalon, Inc.</a>
<a href="http://www.antigenics.com" target="_blank">Antigenics</a> Technology and products to treat cancers, infectious diseases, and autoimmune disorders IPO 2000
<a href="http://www.covidien.com" target="_blank">Aspect Medical Systems, Inc.</a> Pioneer and global market leader in brain monitoring and measurement products Acquired 2010 <a href="http://www.covidien.com" target="_blank">Covidien</a>
AudioLogic, Inc. High performance digital signal processing systems Acquired 1999 <a href="http://www.cirrus.com/" target="_blank">Cirrus Logic</a>
<a href="http://www.aveopharma.com" target="_blank">AVEO Pharmaceuticals, Inc.</a> Discovering, developing and commercializing cancer therapeutics. IPO 2010
<a href="http://www.bg-medicine.com/" target="_blank">BG Medicine, Inc.</a> Developing and delivering diagnostic solutions to aid in the clinical management of heart failure and related disorders. IPO 2011
<a href="http://www.bindtherapeutics.com/" target="_blank">BIND Therapeutics, Inc.</a> Nanomedicine platform company developing Accurins, its novel targeted therapeutics. IPO 2013
<a href="http://www.celera.com" target="_blank">Celera</a> Sequenced human genome; now focused on therapeutics for cancer and other diseases IPO 2000
<a href="http://www.gilead.com/" target="_blank">CGI Pharmaceuticals, Inc.</a> Developing small molecule therapeutics for multiple oncology and immunology-based indications Acquired 2010 <a href="http://www.gilead.com/" target="_blank">Gilead</a>
ChemGenics Pharmaceuticals Genetically directed drug discovery focused on fungal bacterial diseases Acquired 1997 <a href="http://www.mlnm.com" target="_blank">Millennium Pharmaceuticals</a>
<a href="/www.usa.philips.com" target="_blank">Color Kinetics</a> Pioneer in the design, marketing and licensing of intelligent solid-state lighting systems Acquired 2007 <a href="/www.usa.philips.com" target="_blank">Philips</a>
<a href="http://www.concertpharma.com" target="_blank">Concert Pharmaceuticals, Inc.</a> Applying the company’s DCE Platform® (deuterated chemical entity platform) to create novel and differentiated small molecule drugs. IPO 2014
<a href="http://www.hologic.com" target="_blank">CYTYC</a> Design, development, manufacturing, and marketing of medical devices focused on women's health IPO 1996
<a href="http://www.elevenbio.com/" target="_blank">Eleven Biotherapeutics, Inc.</a> Discovering and developing protein therapeutics to treat diseases of the eye. IPO 2014